Raynaud's Syndrome Completed Phase 2 Trials for Botulinum toxin type A (DB00083)

Also known as: Raynaud’s phenomenon / Raynaud's Phenomenon / Raynaud’s syndrome / Raynaud Syndrome / Raynaud / Raynaud's Disease / Raynaud phenomenon / Raynauds / Raynaud's syndrome NOS / Raynauds' phen / Raynaud Disease

IndicationStatusPhase
DBCOND0049133 (Raynaud's Syndrome)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01309802A Two-Part Study of BOTOX® Therapy for Ischemic DigitsTreatment